2020, Cilt 36, Sayı 5, Sayfa(lar) 091-098
Current clinical trials and vaccine development strategies COVID-19 infection and how to manage the risk of future outbreaks (prevention, control, and treatment)
Bahattin Taylan Koç
Adnan Menderes Üniversitesi Veteriner Fakültesi Viroloji Anabilim Dalı, Aydın, Türkiye
Keywords: COVID-19, SARS-CoV2, one health, virology, clinical trials
Downloaded:826 - Viewed: 2014

The main purpose of this article is to provide information on the global clinical trials of treatment and vaccine studies against COVID-19 / SARS-CoV2 infection. In this context, daily data from official companies with strong communication networks in the world and more intensive issues will be considered. The second purpose of the review is to address the treatment and prevention-control criteria that can be applied against COVID-19 / SARS-CoV2 or new outbreaks that may occur in the future. Information will be given about the second and third waves that can be experienced in SARSCoV2, the therapeutics that are more prominent, and the new generation antiviral methods that can be used in other virus infections. Many therapeutic and vaccine trials for COVID-19 / SARS-CoV2 are ongoing. Conducting intensive clinical studies and sharing them instantly on online platforms accelerates the development of treatment and vaccine methods. Prevention-control is still the most important issue, and combating diseases is still the most important and simple criterion. In order to maximize this criterion, struggle with the concept of "One Health, One Medicine, One Virology" should be taken as a basis for every virus with zoonotic potential such as COVID-19 / SARS-CoV2.